EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Octenidine Lozenges Intended for Oral Administration Display In Vitro Activity Against Oropharyngeal Pathogens and Safety Toward Intestinal Microbiota

Adam Junka iD, Malwina Brożyna iD, Paweł Krzyżek iD, Michał Tomczyk iD, Krzysztof Krasucki iD, Tomasz Matys iD, Tomasz Musiała, Marta Stafiniak iD, Andrzej Fal iD

International Journal of Molecular Sciences · 15.10.2025 · 26 (20) · 10045

DOI: 10.3390/ijms262010045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.10.2025. Verfasst von Adam Junka und 8 weiteren Autor:innen. Beteiligte Einrichtung: "P.U.M.A." Platform for Unique Model Application, Department of Translative Technologies, Faculty of Pharmacy, Wroclaw Medical University, Borowska 2…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Pyridines, Oropharynx, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wroclaw Medical University, Internal Wroclaw Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pharyngitis is a leading cause of outpatient antibiotic use, despite its typically viral or self-limiting nature. Such unnecessary antibiotic therapies are not only the cause of increasing antibiotic resistance, but also significant changes in the human microbiota in the intestines and other locations, which translate into immune disorders and an increased risk of developing several chronic diseases. Orally administered octenidine-containing lozenges provide a topical alternative; however, their effects on the host microbiota of the oral cavity, throat, and intestine remain unclear. In this study, we evaluated the antimicrobial and antibiofilm in vitro activity of octenidine lozenges against 106 microbial strains, including pathogens and commensals from the oral cavity, pharynx, and large intestine. Minimal biocidal concentrations (MBCs) and minimal biofilm eradication concentrations (MBECs) were determined under physiologically relevant exposure times: 23 min for oral contact and 24 h for intestinal transit. ADME in silico analysis confirmed the lack of absorption of octenidine through the blood–brain barrier and the gastric intestinal mucosa. At concentrations achievable in saliva and the intestinal lumen, octenidine effectively eradicated in vitro all oropharyngeal pathogens while leaving intestinal commensals unaffected. Its impact on oral commensals resembled that of routine mechanical cleaning. These in vitro findings are of high translative value because they support the use of octenidine lozenges as a safe topical treatment for pharyngeal infections, “sore throat”, without adverse effects on the gut microbiota.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomePyridinesOropharynxAnti-Bacterial AgentsHumansAdministration, OralIminesBiofilmsMicrobial Sensitivity TestsPharyngitis

Stichwörter der Autor:innen

antisepticdysbiosislozengesnormal microbiotaoctenidineoral administrationoral cavity/throat pathogens

Substanzen

octenidinePyridinesIminesAnti-Bacterial Agents

Autor:innen und Institutionen

  • "P.U.M.A." Platform for Unique Model Application, Department of Translative Technologies, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211, 50-534 Wroclaw, Poland.
  • Department of Microbiology, Faculty of Medicine, Wroclaw Medical University, 50-368 Wroclaw, Poland.
  • Division of Laboratory Medicine, Department of Biology and Pharmacognosy, Faculty of Pharmacy, Medical University of Białystok, ul. Mickiewicza 2A, 15-222 Białystok, Poland.
  • Department of Morphology, Universidad de Las Palmas de Gran Canaria, 35016 Las Palmas de Gran Canaria, Spain.
  • Faculty of Medical and Health Sciences, Vizja University, 1-go Sierpnia 8A, 02-134 Warsaw, Poland.
  • Clinical Department of Angiology and Internal Disease, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland.

ORCID-Profile: Adam Junka, Malwina Brożyna, Paweł Krzyżek, Michał Tomczyk, Krzysztof Krasucki, Tomasz Matys, Marta Stafiniak, Andrzej Fal

Förderung

  • Wroclaw Medical University
  • Internal Wroclaw Medical University

Zitieren

APA

Junka, A., Brożyna, M., Krzyżek, P., Tomczyk, M., Krasucki, K., Matys, T., Musiała, T., Stafiniak, M., & Fal, A. (2025). Octenidine Lozenges Intended for Oral Administration Display In Vitro Activity Against Oropharyngeal Pathogens and Safety Toward Intestinal Microbiota. International Journal of Molecular Sciences, 26(20), 10045. https://doi.org/10.3390/ijms262010045

Vancouver

Junka A, Brożyna M, Krzyżek P, Tomczyk M, Krasucki K, Matys T, et al. Octenidine Lozenges Intended for Oral Administration Display In Vitro Activity Against Oropharyngeal Pathogens and Safety Toward Intestinal Microbiota. International Journal of Molecular Sciences. 2025;26(20):10045. doi:10.3390/ijms262010045

BibTeX
@article{Junka2025,
  author = {Junka, Adam and Brożyna, Malwina and Krzyżek, Paweł and Tomczyk, Michał and Krasucki, Krzysztof and Matys, Tomasz and Musiała, Tomasz and Stafiniak, Marta and Fal, Andrzej},
  title = {Octenidine Lozenges Intended for Oral Administration Display In Vitro Activity Against Oropharyngeal Pathogens and Safety Toward Intestinal Microbiota},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {20},
  pages = {10045},
  doi = {10.3390/ijms262010045}
}
Kostenlos starten →